OUR PROJECTS

Pipeline VL1:Enhancement of Cancer Immunotherapy by Facilitate the Access of Cytotoxic T Cell

  • Targeting solid cancers by combination with immuno checkpoint inhibitor

  • First in human: planning to start in 2020

Pipeline VL2:Cancer Peptide Vaccine

  • Targeting cancer stem cells

  • First in human: planning to start in 2020

Pipeline VL3:Vascular Barrier Enhancement

  • Targeting AMD (wet type) and Diabetic retinopathy

  • First in human: TBD

Please reload

© 2018 Vasculead Inc. All Rights Reserved